asentra 50 mg
krka, d.d., novo mesto, slovinsko - sertralín - 30 - antidepressiva
sertralin krka 50 mg
krka, d.d., novo mesto, slovinsko - sertralín - 30 - antidepressiva
sertralin krka 100 mg
krka, d.d., novo mesto, slovinsko - sertralín - 30 - antidepressiva
oxycomp 40 mg/20 mg tablety s predĺženým uvoľňovaním
g.l. pharma gmbh, rakúsko - oxykodón a naloxón - 65 - analgetica - anodyna
oxycomp 30 mg/15 mg tablety s predĺženým uvoľňovaním
g.l. pharma gmbh, rakúsko - oxykodón a naloxón - 65 - analgetica - anodyna
oxycomp 20 mg/10 mg tablety s predĺženým uvoľňovaním
g.l. pharma gmbh, rakúsko - oxykodón a naloxón - 65 - analgetica - anodyna
oxycomp 10 mg/5 mg tablety s predĺženým uvoľňovaním
g.l. pharma gmbh, rakúsko - oxykodón a naloxón - 65 - analgetica - anodyna
oxycomp 5 mg/2,5 mg tablety s predĺženým uvoľňovaním
g.l. pharma gmbh, rakúsko - oxykodón a naloxón - 65 - analgetica - anodyna
pifeltro
merck sharp & dohme b.v. - doravirine - hiv infekcie - antivirotiká na systémové použitie - pifeltro is indicated, in combination with other antiretroviral medicinal products, for the treatment of adults, and adolescents aged 12 years and older weighing at least 35 kg infected with hiv 1 without past or present evidence of resistance to the nnrti class.
vanflyta
daiichi sankyo europe gmbh - quizartinib dihydrochloride - leukémia, myeloid - antineoplastic agents, protein kinase inhibitors - vanflyta is indicated in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by vanflyta single-agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukaemia (aml) that is flt3-itd positive.